Back to Rheumatology

OUR EXPERTISE AND SERVICES AVAILABLE IN

Ankylosing Spondylitis & nr-axSpA

Overview

Spherix’s coverage of the axial spondyloarthritis landscape assesses rheumatologist’s approach to treatment as well as non-radiographic axial spondyloarthritis with a special emphasis on the use of biologics and JAKs. We reserve a special section on gauging reactions to clinical trial results and their impact on future treatment preferences.

Services Available

Trending market evolution

  • Ankylosing Spondylitis & Non-Radiographic Axial Spondyloarthritis (US)

  • Ankylosing Spondylitis & Non-Radiographic Axial Spondyloarthritis (EU)

Service Info

RealTime Dynamix™ is an independent service providing strategic guidance through quarterly or semiannual reports, which include market trending and a fresh infusion of event-driven and variable content with each wave. The reports provide an unbiased view of the competitive landscape within rapidly evolving specialty markets, fueled by robust HCP primary research and our in-house team of experts.

Methodology: Insights are based on data collected from an online survey of respondents recruited from the Spherix Network, a proprietary group of specialty physicians in clinical practice meeting quality screening criteria.

Sample Size and Frequency

US: quarterly report (n=100-200 respondents)

EU5: semiannual report (n=250 respondents)

Canada: semiannual report (n=50 respondents)

Benchmarking new brand performance

  • Rinvoq (AbbVie) in Ankylosing Spondylitis (US)

  • Xeljanz (Pfizer) in Ankylosing Spondylitis (US)

Service Info

Launch Dynamix™ is an independent service providing monthly benchmarking of newly launched products for the first eighteen months of commercial availability, augmented by a quarterly deep dive into promotional activity, barriers to uptake, and patient types gravitating to the launch brand.

Methodology: Insights are based on analyses of quantitative data collected from an online survey of physicians “in the trenches” recruited from the Spherix Network, as well as qualitative interviews conducted with a subset of survey respondents.

Sample Size and Frequency

Monthly KPI benchmarking (n=75 physicians)

Quarterly report (n=75 physicians)

Quarterly qualitative interviews (n=8 physicians)

Gauging impact of disruptive events

  • Rheumatology Biosimilars Today and Tomorrow (US)

  • Multi Specialty Impact of COVID 19 Rheumatology (US)

  • Fellows and Residents (US)

Service Info

Special Topix™ is an independent service that includes access to a report or series of reports based on current events or topics of interest in specialty markets covered by Spherix.

Methodology: Insights are based on data collected from an online survey of respondents recruited from the Spherix Network, a proprietary group of specialty physicians in clinical practice meeting quality screening criteria.

Sample Size and Frequency

Report cadence and deliverable depend upon current event/topic being evaluated.

Learn more about our services

HOW CAN WE PARTNER TOGETHER?

Get more information on Ankylosing Spondylitis & nr-axSpA Coverage